Parimifasor

Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).

Target : Other Targets

CAS Number : 1796641-10-5

Formula Weight : 460.214

Molecular Formula : C18H11Cl2F4N5O

Purity : >98% (HPLC)

Storage : (-20?)

Shipping Conditions : With Ice Pack

Stability : ? 2 years

Research use only, not for human use.